Micro- and Nanotechnology in Vaccine Development

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Science & Nature, Technology, Engineering, Chemical & Biochemical
Cover of the book Micro- and Nanotechnology in Vaccine Development by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780323400299
Publisher: Elsevier Science Publication: September 20, 2016
Imprint: Elsevier Language: English
Author:
ISBN: 9780323400299
Publisher: Elsevier Science
Publication: September 20, 2016
Imprint: Elsevier
Language: English

This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress.

MNT allows the creation of particles that exploit the inherent ability of the human immune system to recognize small particles such as viruses and toxins. In combination with minimal protective epitope design, this permits the creation of immunogenic particles that stimulate a response against the targeted pathogen. The finely tuned response of the human immune system to small particles makes it unsurprising that many of the lead adjuvants and vaccine delivery systems currently under investigation are based on nanoparticles.

  • Provides a comprehensive and unparalleled overview of the role of micro- and nanotechnology in vaccine development
  • Allows researchers to quickly familiarize themselves with the broad spectrum of vaccines and how micro- and nanotechnologies are applied to their development
  • Includes a combination of overview chapters setting out general principles, and focused content dealing with specific vaccines, making it useful to readers from a variety of disciplines
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress.

MNT allows the creation of particles that exploit the inherent ability of the human immune system to recognize small particles such as viruses and toxins. In combination with minimal protective epitope design, this permits the creation of immunogenic particles that stimulate a response against the targeted pathogen. The finely tuned response of the human immune system to small particles makes it unsurprising that many of the lead adjuvants and vaccine delivery systems currently under investigation are based on nanoparticles.

More books from Elsevier Science

Cover of the book Treating Life-Threatening Bleedings by
Cover of the book Analytical Ultracentrifugation by
Cover of the book Multidimensional Systems Signal Processing Algorithms and Application Techniques by
Cover of the book The Infinite-Dimensional Topology of Function Spaces by
Cover of the book International Review of Cell and Molecular Biology by
Cover of the book Analytical Chemistry by
Cover of the book Programming 16-Bit PIC Microcontrollers in C by
Cover of the book Separation, Extraction and Concentration Processes in the Food, Beverage and Nutraceutical Industries by
Cover of the book Essentials of Neuroanesthesia by
Cover of the book Highway Engineering by
Cover of the book Peering Carrier Ethernet Networks by
Cover of the book An Appraisal of the Status of Chagas Disease in the United States by
Cover of the book Evidence-Based Practice with Emotionally Troubled Children and Adolescents by
Cover of the book Herpetology by
Cover of the book Epizootic Ulcerative Fish Disease Syndrome by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy